Nociceptive Behavior Following Hindpaw Burn Injury in Young Rats: Response to Systemic Morphine

Pain Medicine

Volumn 12, Issue 1, 2011, Pages 87-98

  Wang, Shuxing ^a,b   Zhang, Lin ^a   Ma, Yuxin ^a   Chen, Lucy ^a   Tian, Yinghong ^a   Mao, Jianren ^a   Martyn, Jeevendra J A ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

Allodynia; Burn injury; GSK 3 ; Hyperalgesia; NMDAR; NOS; PKB Akt

Indexed keywords

AKT1 PROTEIN; DEXTROMETHORPHAN; GLYCOGEN SYNTHASE KINASE 3BETA; INDUCIBLE NITRIC OXIDE SYNTHASE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEURONAL NITRIC OXIDE SYNTHASE; PENTOBARBITAL; PROTEIN KINASE B; PROTEIN KINASE B BETA; SULFADIAZINE SILVER; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BURN; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; HYPERALGESIA; MALE; NOCICEPTION; NONHUMAN; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE; TREATMENT RESPONSE; UPREGULATION;

EID: 78651225871     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2010.01021.x     Document Type: Article

References (59)

1. Stoddard FJ, Saxe G, Ronfeld H, et al. Acute stree symptoms in young children with burns. J Am Acad Child Adolesc Psychiatry 2006;45:87-93.
2. Stoddard FJ, Sorrentino EA, Ceranoglu TA, et al. Prelimiary evidence for the effects of morphine on posttraumatic stress disorder symptoms in one- to four-year-olds with burns. J Burn Care Res 2009;30:836-43.
3. Wang S, Lim G, Yang L, et al. A rat model of unilateral hindpaw burn injury: slowly developing rightwards shift of the morphine dose-response curve. Pain 2005;116:87-95.
4. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001;357:593-615.
5. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994;269:13725-8.
6. Mabuchi T, Matsumura S, Okuda-Ashitaka E, et al. Attenuation of neuropathic pain by the nociceptin/orphanin FQ antagonist JTC-801 is mediated by inhibition of nitric oxide production. Eur J Neurosci 2003;17:1384-92.
7. LaBuda CJ, Koblish M, Tuthill P, et al. Antinociceptive activity of the selective iNOS inhibitor AR-C102222 in rodent models of inflammatory, neuropathic and post-operative pain. Eur J Pain 2006;10:505-12.
8. Sasaki A, Mabuchi T, Serizawa K, et al. Different roles of nitric oxide synthase-1 and -2 between herpetic and postherpetic allodynia in mice. Neuroscience 2007;150:459-66.
9. Takasu K, Honda M, Ono H, et al. Spinal α2-adrenergic and muscarinic receptors and the NO release cascade mediate supraspinally produced effectiveness of gabapentin at decreasing mechanical hypersensitivity in mice after partial nerve injury. Bri J Pharmaco 2006;148:233-44.
10. Tanabe M, Nagatani Y, Saitoh K, et al. Pharmacological assessments of nitric oxide synthase isoforms and downstream diversity of NO signaling in the maintenance of thermal and mechanical hypersensitivity after peripheral nerve injury in mice. Neuropharmacology 2009;56:702-8.
11. Ji RR, Kohno T, Moore KA, et al. Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci 2003;26:696-705.
12. Meller ST, Dykstra C, Gebhart GF. Production of endogenous nitric oxide and activation of soluble guanylate cyclase are required for N-methyl-d-aspartate-produced facilitation of the nociceptive tail-flick reflex. Eur J Pharmacol 1992a;214:3-96.
13. Meller ST, Pechman PS, Gebhart GF, et al. Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat. Neuroscience 1992b;50:7-10.
14. Wang S, Zhang L, Lim G, et al. A combined effect of dextromethorphan and melatonin on neuropathic pain behavior in rats. Brain Res 2009;1288:42-9.
15. Herndon DN, Wilmore DW, Mason AD. Development and analysis of a small animal model simulating postburn hypermetabolic responses. J Surg Res 1978;25:394-403.
16. Ibebunjo C, Martyn JAJ. Disparate dysfunction of skeletal muscle located near and distant from burn site in the rat. Muscle Nerve 2001;24:1283-94.
17. Kim C, Martyn J, Fuke N. Burn injury of trunk of rat causes denervation-like responses in the gastrocnemius muscle. J Appl Physiol 1988;65:1745-51.
18. Strome DR, Aulick LH, Mason AD Jr, et al. Thermoregulatory and nonthermoregulatory heat production in burned rat. J Appl Physiol 1986;61:688-93.
19. Mao J, Price DD, Mayer DJ. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J Neurosci 1994;14:2301-12.
20. Arturson G. Pathophysiology of burn wound and pharmacological treatment. The Rudi Hermans lecture. Burns 1996;22:255-74.
21. Youn YK, Lalonde C, Demling R. The role of mediators in the response to thermal injury. World J Surg 1992;16:30-6.
22. Nozaki-Taguchi N, Yaksh TL. A novel model of primary and secondary hyperalgesia after mild thermal injury in the rat. Neurosci Lett 1998;254:25-8.
23. Møiniche S, Dahl JB, Kehlet H. Time course of primary and secondary hyperalgesia after heat injury to the skin. Br J Anaesth 1993;71:201-5.
24. Pedersen JL, Kehlet H. Secondary hyperalgesia to heat stimuli after burn injury in man. Pain 1998;76:377-84.
25. Silbert BS, Osgood PF, Carr DB. Burn pain. In: Yaksh TL, ed. Anesthesia: Biologic Foundation. Philadelphia, PA: Lippincott-Raven Publishers; 1997:750-73.
26. Gardell LR, Ibrahim M, Wang R, et al. Mouse strains that lack spinal dynorphin upregulation after peripheral nerve injury do not develop neuropathic pain. Neuroscience 2004;123:43-52.
27. Malmberg AB, Chen C, Tonegawa S, et al. Preserved acute pain and reduced neuropathic pain in mice lacking PKCγ. Science 1997;278:279-83.
28. Mao J, Price DD, Mayer DJ, et al. Pain-related increases in spinal cord membrane-bound protein kinase C following peripheral nerve injury. Brain Res 1992;588:144-9.
29. Mao J, Mayer DJ, Hayes RL, et al. Spatial patterns of increased spinal cord membrane-bound protein kinase C and their relation to increase in 14C-2-deoxyglucose metabolic activity in rats with painful peripheral mononeuropathy. J Neurophysiol 1993;70:470-81.
30. Mao J, Price DD, Phillips LL, et al. Incerases in protein kinase C gamma immunoreactivity in the spinal cord dorsal horn of rats with painful mononeuropathy. Neurosci Lett 1995a;198:75-8.
31. Ohsawa M, Narita M, Mizoguchi H, et al. Involvement of spinal protein kinase C in thermal hyperaigesia evoked by partial sciatic nerve ligation, but not by inflammation in the mouse. Eur J Pharmacol 2000;403:81-5.
32. Honore P, Rogers SD, Schwei MJ, et al. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience 2000;98:585-98.
33. Lim G, Wang S, Zeng Q, et al. Evidence for a long-term influence on morphine tolerance after previous morphine exposure: role of neuronal glucocorticoid receptors. Pain 2005;114:81-92.
34. Löfgren O, Qi Y, Lundeberg T. Inhibitory effects of tachykinin receptor antagonists on thermally induced inflammatory reactions in a rat model. Burn 1999;25:125-9.
35. Mao J, Price DD, Mayer DJ. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain 1995b;61:353-64.
36. Rozisky JR, Dantas G, Adachi LS, et al. Long-term effect of morphine administration in young rats on the analgesic opioid response in adult life. Int J Dev Neurosci 2008;26:561-5.
37. Bellacosa A, Testa JR, Staal SP, et al. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 1991;254:274-7.
38. Okano J, Gaslightwala I, Birnbaum MJ, et al. Akt/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation. J Biol Chem 2000;75:30934-42.
39. Biggs WH III, Meisenhelder J, Hunter T, et al. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci U S A 1999;96:7421-6.
40. Brunet A, Bonni A, Zigmond MJ, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999;96:857-68.
41. Kops GJ, de Ruiter ND, De Vries-Smits AM, et al. Direct control of the forkhead transcription factor AFX by protein kinase B. Nature 1999;398:630-4.
42. Muller DL, Unterwald EM. In vivo regulation of extracellular signal regulated protein kinase (ERK) and protein kinase B (Akt) phosphorylation by acute and chronic morphine. J Pharmacol Exp Ther 2004;310:774-82.
43. Datta SR, Dudek H, Tao X, et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997;91:231-41.
44. Dimmeler S, Fleming I, Fisslthaler B, et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999;399:601-5.
45. Fulton D, Gratton JP, McCabe TJ, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999;399:597-601.
46. Michell BJ, Griffiths JE, Mitchelhill KI, et al. The Akt kinase signals directly to endothelial nitric oxide synthase. Curr Bio 1999;l9:845-8.
47. Ozes ON, Mayo LD, Gustin JA, et al. NF-kappa-B activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1998;401:82-5.
48. Romashkova JA, Makarov SS. NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999;401:86-90.
49. Parkitna JR, Obara I, Wawrzczak-Bargiela A, et al. Effects of glycogen synthase kinase 3beta and cyclin-dependent kinase 5 inhibitors on morphine-induced analgesia and tolerance in rats. J Pharmacol Exp Ther 2006;319:832-9.
50. Pitcher GM, Henry JL. Second phase of formalin-induced excitation of spinal dorsal horn neurons in spinalized rats is reversed by sciatic nerve block. Eur J Neurosci 2002;15:1509-15.
51. Kawamata T, Omote K. Activation of spinal N-methyl-d-aspartate receptors stimulates a nitric oxide/cyclic guanosine 3', 5'-monophosphate/glutamate release cascade in nociceptive signaling. Anesthesiology 1999;91:1415-24.
52. Xu L, Mabuchi T, Katano T, et al. Nitric oxide (NO) serves as a retrograde messenger to activate neuronal NO synthase in the spinal cord via NMDA receptors. Nitric Oxide 2007;17:18-24.
53. Pan HL, Chen SR, Eisenach JC. Role of spinal NO in antiallodynic effect of intrathecal clonidine in neuropathic rats. Anesthesiology 1998;89:1518-23.
54. Song HK, Pan HL, Eisenach JC. Spinal nitric oxide mediates antinociception from intravenous morphine. Anesthesiology 1998;89:215-21.
55. Xu Z, Tong C, Pan HL, et al. Intravenous morphine increases release of nitric oxide from spinal cord by an alpha-adrenergic and cholinergic mechanism. J Neurophysiol 1997;78:2072-8.
56. Zhuo M, Meller ST, Gebhart GF. Endogenous nitric oxide is required for tonic cholinergic inhibition of spinal mechanical transmission. Pain 1993;54:71-8.
57. Schini-Kerth VB. Dual effects of insulin-like growth factor-I on the constitutive and inducible nitric oxide (NO) synthase-dependent formation of NO in vascular cells. J Endocrinol Invest 1999;22:82-8.
58. Jin XG, He SQ, Yan XT, et al. Variants of neural nitric oxide synthase in the spinal cord of neuropathic rats and their effects on nuclear factor-kappaB (NF-kappaB) activity in PC12 cells. J Pain 2009;10:80-9.
59. Kashii S, Mandai M, Kikuchi M, et al. Dual actions of nitric oxide in N-methyl-D-aspartate receptor-mediated neurotoxicity in cultured retinal neurons. Brain Res 1996;711:93-101.